REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:RDC - NL0012044747 - Common Stock
62.8 EUR
-0.7 (-1.1%)
We assign a fundamental rating of 3 out of 10 to RDC. RDC was compared to 25 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of RDC is average, but there are quite some concerns on its profitability. RDC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year RDC has reported negative net income.
RDC had a positive operating cash flow in the past year.
RDC had negative earnings in each of the past 5 years.
Of the past 5 years RDC 4 years had a positive operating cash flow.
1.2 Ratios
RDC's Return On Assets of -2.88% is on the low side compared to the rest of the industry. RDC is outperformed by 80.00% of its industry peers.
The Return On Equity of RDC (-7.01%) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROIC | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RDC has a Gross Margin of 22.88%. This is in the lower half of the industry: RDC underperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of RDC has grown nicely.
The Profit Margin and Operating Margin are not available for RDC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
2. Health
2.1 Basic Checks
RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
RDC has less shares outstanding than it did 1 year ago.
RDC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RDC is higher compared to a year ago.
2.2 Solvency
RDC has an Altman-Z score of 3.28. This indicates that RDC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.28, RDC is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
RDC has a Debt/Equity ratio of 0.62. This is a neutral value indicating RDC is somewhat dependend on debt financing.
RDC has a better Debt to Equity ratio (0.62) than 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.28 |
ROIC/WACCN/A
WACC6.66%
2.3 Liquidity
A Current Ratio of 1.68 indicates that RDC should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.68, RDC belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that RDC should not have too much problems paying its short term obligations.
RDC has a Quick ratio of 1.23. This is amongst the best in the industry. RDC outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
RDC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.61%.
RDC shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.68%.
The Revenue has been growing by 27.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
3.2 Future
The Earnings Per Share is expected to grow by 52.33% on average over the next years. This is a very strong growth
Based on estimates for the next years, RDC will show a quite strong growth in Revenue. The Revenue will grow by 18.74% on average per year.
EPS Next Y50.17%
EPS Next 2Y53.4%
EPS Next 3Y51.27%
EPS Next 5Y52.33%
Revenue Next Year25.49%
Revenue Next 2Y22.82%
Revenue Next 3Y21.23%
Revenue Next 5Y18.74%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
RDC is valuated quite expensively with a Price/Forward Earnings ratio of 92.28.
RDC's Price/Forward Earnings ratio is rather expensive when compared to the industry. RDC is more expensive than 88.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.20. RDC is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 92.28 |
4.2 Price Multiples
RDC's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. RDC is more expensive than 84.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 35.71 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RDC does not grow enough to justify the current Price/Earnings ratio.
RDC's earnings are expected to grow with 51.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.4%
EPS Next 3Y51.27%
5. Dividend
5.1 Amount
No dividends for RDC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:RDC (12/3/2025, 5:29:52 PM)
62.8
-0.7 (-1.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners48.6%
Inst Owner ChangeN/A
Ins Owners7.4%
Ins Owner ChangeN/A
Market Cap1.29B
Revenue(TTM)2.82B
Net Income(TTM)-35.19M
Analysts78.67
Price Target147.49 (134.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)150.51%
Min EPS beat(2)-12.8%
Max EPS beat(2)313.82%
EPS beat(4)2
Avg EPS beat(4)71.29%
Min EPS beat(4)-42.68%
Max EPS beat(4)313.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-1.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.1%
PT rev (3m)-11.58%
EPS NQ rev (1m)39.28%
EPS NQ rev (3m)39.28%
EPS NY rev (1m)1.5%
EPS NY rev (3m)4.3%
Revenue NQ rev (1m)-1.14%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 92.28 | ||
| P/S | 0.46 | ||
| P/FCF | N/A | ||
| P/OCF | 39.39 | ||
| P/B | 2.57 | ||
| P/tB | 12.98 | ||
| EV/EBITDA | 35.71 |
EPS(TTM)-1.75
EYN/A
EPS(NY)0.68
Fwd EY1.08%
FCF(TTM)-2.99
FCFYN/A
OCF(TTM)1.59
OCFY2.54%
SpS137.07
BVpS24.41
TBVpS4.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% | ||
| FCFM | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score3
Asset Turnover2.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.5 | ||
| Cap/Depr | 136.74% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 90.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 3.28 |
F-Score3
WACC6.66%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
EPS Next Y50.17%
EPS Next 2Y53.4%
EPS Next 3Y51.27%
EPS Next 5Y52.33%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
Revenue Next Year25.49%
Revenue Next 2Y22.82%
Revenue Next 3Y21.23%
Revenue Next 5Y18.74%
EBIT growth 1Y-72.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.27%
EBIT Next 3Y97.51%
EBIT Next 5Y68.49%
FCF growth 1Y-2656.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.32%
OCF growth 3Y23.87%
OCF growth 5YN/A
REDCARE PHARMACY NV / RDC.DE FAQ
Can you provide the ChartMill fundamental rating for REDCARE PHARMACY NV?
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE.
What is the valuation status of REDCARE PHARMACY NV (RDC.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to REDCARE PHARMACY NV (RDC.DE). This can be considered as Overvalued.
Can you provide the profitability details for REDCARE PHARMACY NV?
REDCARE PHARMACY NV (RDC.DE) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for RDC stock?
The Earnings per Share (EPS) of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 50.17% in the next year.